1. 2022-RA-1136-ESGO A single-cell map of rare ovarian cancer. (20th October 2022) Authors: Laga, Tina; Busschaert, Pieter; Olbrecht, Siel; Loverix, Liselore; Lodi, Francesca; Baert, Thaïs; Gorp, Toon Van; Rompuy, Anne-Sophie Van; Vergote, Ignace; Lambrechts, Diether; Nieuwenhuysen, Els Van Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer. (20th October 2022) Authors: Loverix, Liselore; Salihi, Rawand; van Rompuy, Anne-Sophie; Vanderstichele, Adriaan; van Nieuwenhuysen, Els; Baert, Thaïs; Debruyne, Philip; Cornez, Nathalie; Henry, Stéphanie; Neven, Patrick; Han, Sileny; Berteloot, Patrick; Olbrecht, Siel; Laga, Tina; Busschaert, Pieter; van Gorp, Toon; Vergote... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1392-ESGO Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: interim results of ENGOT Cx8/GOG-3024/innovaTV205. (20th October 2022) Authors: Lorusso, Domenica; Vergote, Ignace; O'Cearbhaill, Roisin E; Westermann, Anne M; Banerjee, Susana; van Nieuwenhuysen, Els; Iglesias, David A; Collins, Dearbhaile; Cibula, David; Madsen, Kristine; Tewari, Krishnansu S; Pignata, Sandro; Baurain, Jean-Francois; Boere, Ingrid A; Denys, Hannelore; Andr... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-1473-ESGO Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in recurrent ovarian cancer – results of the Leuven HRD test. (20th October 2022) Authors: Loverix, Liselore; Vergote, Ignace; Vanderstichele, Adriaan; Busschaert, Pieter; Boeckx, Bram; Venken, Tom; van Nieuwenhuysen, Els; Baert, Thaïs; Han, Sileny; Neven, Patrick; Berteloot, Patrick; Olbrecht, Siel; Laga, Tina; Lambrechts, Diether; van Gorp, Toon Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. (20th October 2022) Authors: Vergote, Ignace; Mirza, Mansoor; Sehouli, Jalid; Lorusso, Domenico; Kose, Fatih; Cibula, David; Westermann, Anneke; Collins, Dearbhaile; Banerjee, Susana; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley J Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022-RA-276-ESGO Value of surgical cytoreduction for subsequent ovarian cancer relapse in patients previously treated with chemotherapy alone at 1st-relapse: a subanalysis of the DESKTOP III/ENGOT-ov20 trial. (20th October 2022) Authors: Fotopoulou, Christina; Sehouli, Jalid; Vergote, Ignace; Reuss, Alexander; Leheurteur, Marianne; Hilpert, Felix; Savoye, Aude-Marie; Greggi, Stefano; Vernersson, Johanna; Resch, Benoît; Gatineau, Michel; Levêque, Jean; Zang, Rongyu; Jensen, Pernille T; Kim, Jae W; Santiago, Domingo; Raspagliesi, F... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2022-RA-873-ESGO Validation study of the 'NOGGO-GIS ASSAY' based on ovarian cancer samples from the first-line PAOLA-1/ENGOT-ov25 phase-III trial. (20th October 2022) Authors: Willing, Eva-Maria; Vollbrecht, Claudia; Voessing, Christine; Weist, Peggy; Schallenberg, Simon; Jori, Balazs; Tiemann, Markus; Bataillon, Guillaume; Harter, Philipp; Pignata, Sandro; Martin, Antonio Gonzales; Vergote, Ignace; Colombo, Nicoletta; Marth, Christian; Berg, Tobias; Kah, Bettina; Herb... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101). (10th December 2020) Authors: Berton-Rigaud, Dominique; Vergote, Ignace; Pautier, Patricia; Kryzhanivska, Anna; Angelergues, Antoine; Kornacki, Deanna; Dudzisz-Sledz, Monika; Tian, Chuan; Bourayou, Nawel; Selle, Frederic Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101). (9th November 2020) Authors: Berton-Rigaud, Dominique; Vergote, Ignace; Pautier, Patricia; Kryzhanivska, Anna; Angelergues, Antoine; Kornacki, Deanna; Dudzisz-Sledz, Monika; Tian, Chuan; Bourayou, Nawel; Selle, Frederic Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer. Issue 2 (1st February 2017) Authors: Pautier, Patricia; Vergote, Ignace; Joly, Florence; Melichar, Bohuslav; Kutarska, Elzbieta; Hall, Geoffrey; Lisyanskaya, Anna; Reed, Nicholas; Oaknin, Ana; Ostapenko, Valerijus; Zvirbule, Zanete; Chetaille, Eric; Geniaux, Agnès; Shoaib, Muhammad; Green, John A. Journal: International journal of gynecological cancer Issue: Volume 27:Issue 2(2017) Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗